Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
02 09 2019
Historique:
received: 27 07 2018
accepted: 24 07 2019
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 31 12 2019
Statut: epublish

Résumé

The serotonergic system and in particular serotonin 1A receptor (5-HT1AR) are implicated in major depressive disorder (MDD). Here we demonstrated that 5-HT1AR is palmitoylated in human and rodent brains, and identified ZDHHC21 as a major palmitoyl acyltransferase, whose depletion reduced palmitoylation and consequently signaling functions of 5-HT1AR. Two rodent models for depression-like behavior show reduced brain ZDHHC21 expression and attenuated 5-HT1AR palmitoylation. Moreover, selective knock-down of ZDHHC21 in the murine forebrain induced depression-like behavior. We also identified the microRNA miR-30e as a negative regulator of Zdhhc21 expression. Through analysis of the post-mortem brain samples in individuals with MDD that died by suicide we find that miR-30e expression is increased, while ZDHHC21 expression, as well as palmitoylation of 5-HT1AR, are reduced within the prefrontal cortex. Our study suggests that downregulation of 5-HT1AR palmitoylation is a mechanism involved in depression, making the restoration of 5-HT1AR palmitoylation a promising clinical strategy for the treatment of MDD.

Identifiants

pubmed: 31477731
doi: 10.1038/s41467-019-11876-5
pii: 10.1038/s41467-019-11876-5
pmc: PMC6718429
doi:

Substances chimiques

MicroRNAs 0
Mirn30d microRNA, mouse 0
Receptor, Serotonin, 5-HT1A 112692-38-3
Acyltransferases EC 2.3.-
Zdhhc21 protein, mouse EC 2.3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3924

Références

J Biol Chem. 2012 Jan 2;287(1):523-30
pubmed: 22081607
Biochem Soc Trans. 2015 Apr;43(2):193-8
pubmed: 25849916
Neuropsychopharmacology. 2006 Jan;31(1):101-11
pubmed: 15920501
Cell Rep. 2017 May 30;19(9):1767-1782
pubmed: 28564597
Pharmacol Biochem Behav. 2014 Jul;122:240-5
pubmed: 24732636
J Affect Disord. 2010 Dec;127(1-3):332-6
pubmed: 20579744
Schizophr Res. 2010 Dec;124(1-3):183-91
pubmed: 20675101
Mol Cell. 2008 Jan 18;29(1):1-7
pubmed: 18206964
Int J Cancer Suppl. 1994;8:38-42
pubmed: 7515028
Elife. 2015 Dec 23;4:e11306
pubmed: 26701913
Mol Cell Biol. 2016 Aug 12;36(17):2208-25
pubmed: 27247265
Neuropsychopharmacology. 2004 Nov;29(11):2007-17
pubmed: 15266352
Curr Opin Neurobiol. 2017 Aug;45:210-220
pubmed: 28366531
Neuron. 2004 Dec 16;44(6):987-96
pubmed: 15603741
Neuroscience. 1997 Dec;81(3):689-97
pubmed: 9316021
Nature. 2007 Jan 11;445(7124):168-76
pubmed: 17151600
J Proteomics. 2012 Jul 16;75(13):4062-73
pubmed: 22641154
Biol Psychiatry. 2004 Feb 1;55(3):225-33
pubmed: 14744462
J Cell Sci. 2012 May 15;125(Pt 10):2486-99
pubmed: 22357950
Psychiatr Genet. 1999 Jun;9(2):105-6
pubmed: 10412191
Behav Brain Res. 2010 Mar 17;208(1):265-9
pubmed: 19913057
Nat Neurosci. 2014 Apr;17(4):522-32
pubmed: 24562000
J Neurosci. 2010 Nov 10;30(45):15007-18
pubmed: 21068306
Biochem J. 2013 Dec 15;456(3):311-22
pubmed: 24059268
BMC Neurosci. 2012 Sep 18;13:110
pubmed: 22989159
Genome Biol. 2007;8(2):R27
pubmed: 17326821
Methods Cell Biol. 2013;117:243-65
pubmed: 24143982
Mol Cell Proteomics. 2018 Feb;17(2):233-254
pubmed: 29217618
J Neurosci. 1998 Sep 15;18(18):7394-401
pubmed: 9736659
Biol Psychiatry. 2006 May 15;59(10):958-65
pubmed: 16458263
Psychopharmacology (Berl). 2001 Apr;155(1):110-2
pubmed: 11374330
J Neurosci. 2002 Aug 15;22(16):7154-64
pubmed: 12177211
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2422-7
pubmed: 16461918
Biochim Biophys Acta. 2006 Apr;1761(4):474-83
pubmed: 16647879
Biochem Pharmacol. 2004 Feb 1;67(3):479-90
pubmed: 15037200
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10734-9
pubmed: 9724773
Eur J Pharmacol. 2010 May 25;634(1-3):62-7
pubmed: 20176013
Int J Neuropsychopharmacol. 2008 Jun;11(4):465-76
pubmed: 17971260
Nature. 1977 Apr 21;266(5604):730-2
pubmed: 559941
Nat Rev Neurosci. 2010 Mar;11(3):161-75
pubmed: 20168314
Brain Behav Immun. 2013 Mar;29:136-146
pubmed: 23305936
J Psychiatr Res. 2011 Jan;45(1):92-5
pubmed: 20546789
Neuroscience. 2004;125(1):47-55
pubmed: 15051144
Eur J Pharmacol. 2003 Dec 15;482(1-3):197-203
pubmed: 14660023
Cell Rep. 2019 Jan 2;26(1):209-221.e5
pubmed: 30605677
Biol Psychiatry. 1994 Sep 15;36(6):381-8
pubmed: 7803599
Arch Gen Psychiatry. 2000 Feb;57(2):174-80
pubmed: 10665620
Am J Med Genet. 1995 Oct 9;60(5):393-9
pubmed: 8546152
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Nat Med. 2014 Jul;20(7):764-8
pubmed: 24908571
Behav Brain Res. 2015 Jan 1;276:118-29
pubmed: 24786329
J Affect Disord. 2016 Apr;194:109-14
pubmed: 26807671
Methods Mol Biol. 2014;1156:213-22
pubmed: 24791991
Nucl Med Biol. 2000 Jul;27(5):499-507
pubmed: 10962258
J Neurosci Methods. 2008 May 30;170(2):345-51
pubmed: 18342949
J Biol Chem. 2011 Jul 1;286(26):23419-31
pubmed: 21454618
Neuropsychopharmacology. 2017 Mar;42(4):864-875
pubmed: 27577603
J Neurosci. 2007 Jun 20;27(25):6729-39
pubmed: 17581960
Nature. 2017 Sep 21;549(7672):399-403
pubmed: 28869973
Nat Methods. 2013 Jan;10(1):54-6
pubmed: 23160281
J Biol Chem. 2004 Jan 30;279(5):3280-91
pubmed: 14604995
Neurosci Biobehav Rev. 2009 Jul;33(7):1089-98
pubmed: 19463853
Nature. 2002 Mar 28;416(6879):396-400
pubmed: 11919622
Neuropsychopharmacology. 2006 Aug;31(8):1745-9
pubmed: 16395308
Neuropsychopharmacology. 2009 Sep;34(10):2275-84
pubmed: 19458612
Mol Pharmacol. 2007 Sep;72(3):502-13
pubmed: 17540717
PLoS Genet. 2009 Nov;5(11):e1000748
pubmed: 19956733
J Neurosci. 2016 Jun 15;36(24):6431-44
pubmed: 27307232
Neuron. 2012 Feb 9;73(3):482-96
pubmed: 22325201
Behav Pharmacol. 2005 May;16(3):171-80
pubmed: 15864072
J Mol Neurosci. 2010 Jan;40(1-2):47-55
pubmed: 19711202
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17534-9
pubmed: 25422474
Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17898-903
pubmed: 24127608
Prog Neurobiol. 2017 Apr;151:35-56
pubmed: 27013076
Oncogene. 2012 May 31;31(22):2750-60
pubmed: 21963845
Am J Med Genet. 1998 Sep 7;81(5):434-9
pubmed: 9754630
Biol Psychiatry. 2006 Jan 15;59(2):106-13
pubmed: 16154547

Auteurs

Nataliya Gorinski (N)

Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Monika Bijata (M)

Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.
Cell Biophysics, Nencki Institute, Pasteur Str. 3, 02-093, Warsaw, Poland.

Sonal Prasad (S)

Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Alexander Wirth (A)

Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Dalia Abdel Galil (D)

Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Andre Zeug (A)

Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Daria Bazovkina (D)

Behavioural Neurogenomics, Institute of Cytology and Genetics, Novosibirsk, 630090, Russia.

Elena Kondaurova (E)

Behavioural Neurogenomics, Institute of Cytology and Genetics, Novosibirsk, 630090, Russia.

Elizabeth Kulikova (E)

Behavioural Neurogenomics, Institute of Cytology and Genetics, Novosibirsk, 630090, Russia.

Tatiana Ilchibaeva (T)

Behavioural Neurogenomics, Institute of Cytology and Genetics, Novosibirsk, 630090, Russia.

Monika Zareba-Koziol (M)

Cell Biophysics, Nencki Institute, Pasteur Str. 3, 02-093, Warsaw, Poland.

Francesco Papaleo (F)

Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, 16163, Genova, Italy.

Diego Scheggia (D)

Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, 16163, Genova, Italy.

Gaga Kochlamazashvili (G)

Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, 16163, Genova, Italy.

Alexander Dityatev (A)

Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, 16163, Genova, Italy.
Molecular Neuroplasticity, DZNE, Leipziger Str. 44, 39120, Magdeburg, Germany.

Ian Smyth (I)

Anatomy & Developmental Biology, Monash University, 3800, Melbourne, Australia.

Adam Krzystyniak (A)

Cell Biophysics, Nencki Institute, Pasteur Str. 3, 02-093, Warsaw, Poland.

Jakub Wlodarczyk (J)

Cell Biophysics, Nencki Institute, Pasteur Str. 3, 02-093, Warsaw, Poland.

Diethelm W Richter (DW)

Neuro and Sensory Physiology, University of Göttingen, 37073, Göttingen, Germany.

Tatyana Strekalova (T)

Sechenov First Moscow State Medical University, Moscow, Russia.
Neuroscience, Maastricht University, 6229 ER, Maastricht, Netherlands.
Laboratory of Psychiatric Neurobiology and Institute of General Pathology and Pathophysiology, Sechenov First Moscow State Medical University, Trubetskaya 8, 119315, Moscow, Russia.

Stephan Sigrist (S)

Institute of Biology, Free University Berlin, Takustr. 6, 14195, Berlin, Germany.

Claudia Bang (C)

Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Lisa Hobuß (L)

Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Jan Fiedler (J)

Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Thomas Thum (T)

Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.

Vladimir S Naumenko (VS)

Behavioural Neurogenomics, Institute of Cytology and Genetics, Novosibirsk, 630090, Russia. naumenko2002@mail.ru.

Ghanshyam Pandey (G)

Department of Psychiatry, University of Illinois, 1601 W. Taylor Street, Chicago, IL, 60612, USA. GPandey@psych.uic.edu.

Evgeni Ponimaskin (E)

Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany. Ponimaskin.evgeni@mh-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH